SABCS 2022: Breast Cancer Index Effective in Predicting Patients Who Would Benefit From Ovarian Suppression Therapy
The genomic assay was also prognostic of distant recurrence
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.